Getting Zanzalintinib (XL092) Covered by Humana in New Jersey: Clinical Trial Access and Compassionate Use Guide
Quick Answer: Your Path to Zanzalintinib Access in New Jersey
Zanzalintinib (XL092) is investigational and not FDA-approved, so Humana won't cover the drug itself—but you have two main paths: clinical trials (free drug) or compassionate use (free drug, insurance covers monitoring). In New Jersey, if Humana denies